Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-05T09:26:14.317Z Has data issue: false hasContentIssue false
  • English
  • Français

Pharmacotherapy for co-occurring alcohol and drug disorders in schizophrenia and bipolar disorder: where is the evidence?

Published online by Cambridge University Press:  24 June 2014

Dan I. Lubman  and
Michael Berk
Dan I. Lubman*
Affiliation:
Orygen Youth Health Research Centre, Centre for Youth Mental Health, University of Melbourne, Victoria, Australia
Michael Berk
Affiliation:
Orygen Youth Health Research Centre, Centre for Youth Mental Health, University of Melbourne, Victoria, Australia
*
Associate Professor Dan I. Lubman, Orygen Youth Health Research Centre, Centre for Youth Mental Health, University of Melbourne, 35 Poplar Rd (Locked Bag 10), Parkville, Victoria 3052, Australia. Tel: 61 3 9342 2888; Fax: 61 3 9342 2941; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Intervention Insights
Information
Acta Neuropsychiatrica , Volume 22 , Issue 2 , April 2010 , pp. 95 - 97
Copyright
Copyright © 2010 John Wiley & Sons A/S

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Regier, DA, Farmer, ME, Rae, DSet al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) study. JAMA 1990;264:2511–2518. CrossRefGoogle ScholarPubMed
Lubman, DI, Sundram, S.Substance misuse in patients with schizophrenia: a primary care guide. Med J Aust 2003;178:S71–S75. Google ScholarPubMed
Green, AI, Noordsy, DL, Brunette, MF, O’Keefe, C.Substance abuse and schizophrenia: pharmacotherapeutic intervention. J Subst Abuse Treat 2008;34:61–71. CrossRefGoogle ScholarPubMed
Lambert, M, Conus, P, Lubman, DIet al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand 2005;112:141–148. CrossRefGoogle ScholarPubMed
Kemp, DE, Gao, K, Ganocy, SJ, Elhaj, O, Bilali, SR, Conroy, C, Findling, RL, Calabrese, JR.A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. J Clin Psychiatry 2009;70:113–121. CrossRefGoogle ScholarPubMed
Mathias, S, Lubman, DI, Hides, L.Substance-induced psychosis: a diagnostic conundrum. J Clin Psychiatry 2008;69:358–367. CrossRefGoogle ScholarPubMed
San, L, Arranz, B, Martinez-Raga, J.Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders. Eur Addict Res 2007;13:230–243. CrossRefGoogle ScholarPubMed
Baker, A, Hides, L, Lubman, DI.Treatment of cannabis use among people with psychotic and depressive disorders: a systematic review. J Clin Psychiatry 2010 (in press).CrossRefGoogle ScholarPubMed
Rubio, G, Martinez, I, Ponce, G, Jimenez-Arriero, MA, Lopez-Munoz, F, Alamo, C.Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity. Can J Psychiatry 2006;51:531–539. CrossRefGoogle ScholarPubMed
Brown, ES, Garza, M, Carmody, TJ.A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. J Clin Psychiatry 2008;69:701–705. CrossRefGoogle ScholarPubMed
Nejtek, VA, Avila, M, Chen, LAet al. Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial. J Clin Psychiatry 2008;69:1257–1266. CrossRefGoogle ScholarPubMed
Salloum, IM, Cornelius, JR, Daley, DC, Kirisci, L, Himmelhoch, JM, Thase, ME.Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 2005;62:37–45. CrossRefGoogle ScholarPubMed
Petrakis, IL, Nich, C, Ralevski, E.Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Schizophr Bull 2006;32:644–654. CrossRefGoogle Scholar
Drake, RE, O’Neal, EL, Wallach, MA.A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat 2008;34:123–138. CrossRefGoogle ScholarPubMed